• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

MRTX-1257 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5755229

MRTX-1257 is a selective, irreversible, and covalent inhibitor of KRAS G12C. It has an IC50 of 900 pM for KRAS dependent ERK phosphorylation in H358 cells.MRTX1257 demonstrated 31% bioavailability in the mouse, with free fraction exposures well above the… More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
MRTX-1257, Inhibitor
Full Product Name
MRTX-1257
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
565.71
Solubility
DMSO: 54mg/mL (95.46mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C33H39N7O2
SMILES
CN1CCC[C@H]1COc1nc2CN(CCc2c(n1)N1CCN([C@@H](CC#N)C1)C(=O)C=C)c1cccc2cccc(C)c12
CAS Number
2206736-04-9
Target & IC50
KRAS(G12C)
In Vitro
MRTX-1257 shows sustained regression at 3,10, 30, and 100mg/kg dose groups. MRTX-1257 dosed of 100mg/kg daily causes complete responses that are maintained >70 days after cessation of treatment, MRTX-1257 (1mg/kg, 3mg/kg, 10mg/kg, 30mg/kg and 100mg/kg, orally, daily for 30 days) displays rapid tumor growth inhibition at all dose groups in MIA PaCa-2 G12C Xenograft model in mice.

Product Categories/Family for MRTX-1257, inhibitor

Structure of MRTX-1257, inhibitor

MRTX-1257 Inhibitor – Cat# MBS5755229

Product References and Citations for MRTX-1257, inhibitor

Matthew et al. Structure-Based Drug Discovery of MRTX1257, a Selective, Covalent KRAS G12C Inhibitor with Oral Activity in Animal Models of Cancer.

Other Notes

Small volumes of MRTX-1257, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for MRTX-1257 purchase

MBS5755229 is an inhibitor targeting MRTX-1257.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000